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Background: Sustained changes in network activity cause homeostatic synaptic plasticity in part by altering the
postsynaptic accumulation of N-methyl-D-aspartate receptors (NMDAR) and α-amino-3-hydroxyle-5-methyl-4-
isoxazolepropionic acid receptors (AMPAR), which are primary mediators of excitatory synaptic transmission. A key
trafficking modulator of NMDAR and AMPAR is STriatal-Enriched protein tyrosine Phosphatase (STEP61) that opposes
synaptic strengthening through dephosphorylation of NMDAR subunit GluN2B and AMPAR subunit GluA2.
However, the role of STEP61 in homeostatic synaptic plasticity is unknown.
Findings: We demonstrate here that prolonged activity blockade leads to synaptic scaling, and a concurrent decrease in
STEP61 level and activity in rat dissociated hippocampal cultured neurons. Consistent with STEP61 reduction, prolonged
activity blockade enhances the tyrosine phosphorylation of GluN2B and GluA2 whereas increasing STEP61 activity blocks
this regulation and synaptic scaling. Conversely, prolonged activity enhancement increases STEP61 level and activity, and
reduces the tyrosine phosphorylation and level of GluN2B as well as GluA2 expression in a STEP61–dependent manner.
Conclusions: Given that STEP61-mediated dephosphorylation of GluN2B and GluA2 leads to their internalization, our results
collectively suggest that activity-dependent regulation of STEP61 and its substrates GluN2B and GluA2 may contribute to
homeostatic stabilization of excitatory synapses.
Keywords: STEP, GluN2B, GluA2, Tyrosine phosphorylation, Tetrodotoxin, Bicuculline, Hippocampal neurons, Homeostatic
plasticity, Synaptic scalingFindings
Background
In response to sustained changes in neuronal activity,
homeostatic synaptic plasticity maintains synaptic strength
and flexibility within physiological limit. This plasticity is
expressed in part by dynamic changes in the postsynaptic
levels of NMDARs and AMPARs that mediate excitatory* Correspondence: chunghj@life.illinois.edu
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both NMDAR and AMPAR is STEP61, a protein tyrosine
(Tyr) phosphatase in the central nervous system that has
two main alternatively spliced forms, the cytosolic STEP46
and the membrane-associated STEP61 [2]. Tightly associ-
ated with the postsynaptic density, STEP61 regulates the
Tyr phosphorylation and surface density of NMDARs and
AMPARs [3–6]. This regulation contributes to Hebbian
long-term potentiation [4, 7] and several neuropsychiatric
disorders most notably Alzheimer’s disease [4] and Fragile
X-syndrome [2].
We have previously identified mRNA transcripts whose
expressions are regulated by prolonged activity perturbation
[8] due to a critical role of transcription in homeostaticdistributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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scripts, we identified PTPN5 that encodes STEP [8]. The
present study investigated whether STEP61 contributes to
homeostatic synaptic plasticity.
Results and discussion
Prolonged alterations of hippocampal network activity
regulate STEP61 level and activity
Prolonged blockade of network activity for 48 h with the
sodium channel blocker tetrodotoxin (TTX) induced syn-
aptic scaling in dissociated hippocampal cultured neurons
as demonstrated previously [11, 12] (Fig. 1a–d), and re-
duced STEP61 mRNA and protein expression compared to
CTL treatment (Fig. 1e, f). Conversely, prolonged activity
enhancement for 48 h using the GABAA receptor antagon-
ist bicuculline (BC) increased STEP61 protein level (Fig. 1g),
but did not alter its mRNA level and the miniature excita-
tory postsynaptic current (mEPSC) (Fig. 1a–e).Fig. 1 Prolonged alterations of hippocampal network activity induce home
patch clamp recording of miniature excitatory postsynaptic currents (mEPS
that were treated for 48 h with vehicle control (CTL, 0.1 % H2O), TTX (1 μM), o
b Normalized cumulative fraction of the mEPSC amplitudes. c–d Summary p
TTX (n = 20), or BC (n = 16). TTX treatment for 48 h induced synaptic scaling w
(n = 5) analyses revealed that 48 h application of TTX but not BC reduced the
STEP61 following 48 h administration of CTL, TTX (F), BC (g) (n = 9 per treatmeTo test whether prolonged TTX or BC treatment affects
STEP61 activity, we examined the phosphorylation of
STEP61 at Ser
221 within its kinase-interactive motif do-
main, which prevents STEP61 interaction with all known
substrates (Fig. 2a) [13]. TTX treatment for 36–48 h en-
hanced Ser221–phosphorylation of STEP61, indicating de-
creased STEP61 activity (Fig. 2b, d). In contrast, 36–48 h
BC treatment reduced Ser221–phosphorylation, indicating
increased STEP61 activity (Fig. 2c, d).
Prolonged alterations of hippocampal network activity
regulate Tyr-phosphorylation of GluN2B and GluA2 in a
STEP61-dependent manner
STEP61 dephosphorylates the NMDAR subunit GluN2B
at Tyr1472 [5, 6] and reduces Tyr-phosphorylation of the
AMPAR subunit GluA2 following group 1 metabotropic
glutamate receptor (mGluR) stimulation [3]. Although the
specific Tyr residues on GluA2 regulated by STEP61 areostatic synaptic plasticity and regulate STEP61 level. a–d Whole-cell
Cs) from rat dissociated hippocampal neurons cultured in high density
r BC (20 μM) at 12–14 days in vitro. a Representative traces of mEPSCs.
lots of average mEPSC amplitudes (c) and frequencies (d) for CTL (n = 19),
hereas 48 h BC treatment had no effect. e Microarray (n = 4) and QPCR
expression of PTPN5, which encodes STEP. f–g Immunoblot analysis of
nt). Data shown represent the mean ± SEM (*p < 0.05; **p < 0.01)
Fig. 2 Prolonged alterations of hippocampal network activity regulate STEP61 activity. a A schematic depicting the regulation of STEP61 activity
by its phosphorylation at Ser221 within its kinase-interactive motif, a binding site for all STEP substrates. b–d Immunoblot analysis of STEP61 and
Ser221–phosphorylated STEP61 (STEP61-pS
221) in hippocampal cultured neurons following CTL, TTX, or BC treatment for 24–48 h (n= 3 per treatment). b, d
Prolonged TTX treatment reduced STEP61 protein level and activity. c, d Prolonged BC treatment enhanced STEP61 protein level and activity. d The relative
phosphorylation state of STEP61 as calculated by the ratio of STEP61-pS
221 level over total STEP61 level. Data shown represent the mean ± SEM
(*p < 0.05; **p < 0.01; ***p < 0.005)
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Tyr873, and Tyr876 (3Tyr) regulates AMPAR trafficking [14].
To determine if the TTX- or BC-induced changes in
STEP61 alter Tyr-phosphorylation of GluN2B and GluA2,
we performed immunoblot analyses using specific anti-
bodies to phosphorylated Tyr1472 of GluN2B [6] and phos-
phorylated 3Tyr of GluA2 [14] (Fig. 3).
Consistent with the TTX-induced decrease in STEP61
level and activity (Fig. 2b, d), prolonged TTX treatment
increased the levels of Tyr1472-phosphorylated GluN2B
(GluN2B-pY1472) and 3Tyr-phopshorylated GluA2 (GluA2-
p3Y) compared to CTL treatment without affecting their
total protein expression (Fig. 3a–c). In contrast, BC treat-
ment for 24–48 h decreased the levels of GluN2B-pY1472
and GluA2-p3Y (Fig. 3d–f ), concurrently with an increase
in STEP61 level and activity (Fig. 2c, d). Interestingly, total
levels of GluN2B and GluA2 were reduced by 48 h BC
application (Fig. 3d, e).We next examined if STEP61 mediates the TTX- or
BC-induced changes in Tyr-phosphorylation of GluN2B
and GluA2. Transactivator of transcription (TAT) se-
quence was fused to STEP46 and a myc tag (Fig. 4a), allow-
ing the TAT fusion proteins to be membrane permeable
(Additional file 1: Figure S1A, B) [15]. Preincubation for
30 min with active TAT-STEP wild-type (WT) but not
control inactive TAT-myc reduced the levels of GluN2B-
pY1472 and GluA2-p3Y in CTL-treated neurons (Fig. 4b, c,
Additional file 1: Figure S1C) and occluded the TTX-
induced increase in GluN2B-pY1472 and GluA2-p3Y levels
compared to CTL application (Fig. 4b, c), suggesting that
the increase in Tyr-phosphorylation of GluN2B and GluA2
is mediated by the TTX-induced reduction in STEP61.
In TAT-STEP C/S, a C300S point mutation inactivates
STEP46, allowing it to bind constitutively to substrates
but not to dephosphorylate them [13, 15, 16]. Consistently,
introduction of TAT-STEP C/S in CTL-treated neurons
Fig. 3 Prolonged alterations of hippocampal network activity regulate Tyr-phosphorylation and levels of GluN2B and GluA2. Immunoblot analysis
of hippocampal cultured neurons that were treated for 48 h with CTL, 24–48 h TTX (a–c), or 24–48 h BC treatment (d–f) (n= 6 per treatment). a–c Prolonged
TTX treatment increased the level of Tyr1472–phosphorylated GluN2B (GluN2B-pY1472) (a) and the level of GluA2 that were phosphorylated at Tyr 869, Tyr 873,
and Tyr 876 (3Tyr) (GluA2-p3Y) (b). d–f Prolonged BC treatment decreased the levels of GluN2B-pY1472 (d) and GluA2-p3Y (e). Total GluN2B and GluA2 levels
were reduced at 48 h BC application. c, f The relative phosphorylation state of GluN2B and GluA2 as calculated by the ratio of phosphorylated proteins over
total proteins followed by normalization to GAPDH. Data shown represent the mean± SEM (*p< 0.05; **p< 0.01)
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GluA2-p3Y compared to TAT-myc application (Fig. 4d, e,
Additional file 1: Figure S1D). Preincubation with TAT-
STEP C/S but not TAT-myc blocked the BC-induced re-
duction in the levels of GluN2B-pY1472, total GluN2B, and
total GluA2 but not GluA2-p3Y (Fig. 4d, e). Since specific
Tyr residues regulated by STEP61 remain unknown, our
analyses for GluA2-p3Y may not have revealed the effect of
TAT-STEP C/S if STEP61 causes dephosphorylation of only
one Tyr. Nonetheless, these results suggest that STEP61
mediates the BC-induced changes in Tyr1472-phosphoryl-
ation of GluN2B and abundance of GluN2B and GluA2.
Enhancement of STEP activity blocks synaptic scaling
Dephosphorylation of Tyr1472 within a conserved endocytic
motif of GluN2B [17] via STEP61 reduces surface NMDAR
level [4, 6] by clathrin-mediated internalization [18]. Fur-
thermore, AMPAR internalization can be induced by
mGluR stimulation through STEP61 [3] and by dephosphor-
ylation of GluA2 at 3Tyr [14]. We hypothesized that pro-
longed activity blockade induces synaptic scaling (Fig. 1a–d)by inhibiting endocytosis of synaptic NMDARs and
AMPARs upon STEP61 reduction (Fig. 1f, Fig 2b). To test
this, we enhanced STEP activity by administering TAT-
STEP WT for 30 min prior to recording. In the presence of
TAT-myc, 48 hTTX treatment increased the mEPSC ampli-
tude but not frequency compared to CTL application
(Fig. 5a–d). However, this TTX-induced synaptic scaling was
abolished by TAT-STEPWT preincubation (Fig. 5a–d), indi-
cating that STEP61 reduction contributes to synaptic scaling.
Interestingly, prolonged activity enhancement increased
STEP61 (Fig. 1g, Fig. 2c) and decreased Tyr-phosphorylation
of GluN2B and GluA2 (Fig. 3d–f, Fig. 4d, e) without indu-
cing synaptic down-scaling (Fig. 1a–d), suggesting that this
STEP61 upregulation may cause internalization of extrasy-
naptic GluN2B and GluA2. Indeed, activity-dependent
AMPAR endocytosis requires GluA2 [19] and occurs extra-
synaptically [20]. Similarly, GluN2B-containing NMDARs
enriched in extrasynaptic sites [21] undergo robust
endocytosis [17, 18]. The BC-induced STEP61-dependent
decrease in GluA2 and GluN2B abundance (Fig. 3d, e,
Fig. 4d, e) may provide an additional homeostatic defense
Fig. 4 TAT-STEP WT or C/S blocks the activity-induced bidirectional changes in GluN2B and GluA2. a A simplified schematic (not to scale) of
cell-permeable TAT-STEP molecular tools. b–e Immunoblot analysis of hippocampal cultured neurons that were treated for CTL, TTX (b–c), or
BC (d–e) for 24 h and 48 h (n = 8 per treatment). Prior to neuronal lysate preparation, neurons were preincubated for 30 min with TAT-myc,
TAT-STEP WT, or TAT-STEP C/S proteins. b–c TAT-STEP WT blocked the TTX-induced increase in Tyr1472–phosphorylation of GluN2B (GluN2B-pY1472) (b)
and 3Tyr-phosphorylation of GluA2 (GluA2-p3Y) (c). d–e TAT-STEP C/S blocked the BC-induced reduction in Tyr1472–phosphorylation and level of GluN2B
(d) as well as GluA2 level but not 3Tyr–phosphorylation of GluA2 (e). Data shown represent the mean ± SEM following normalization to CTL values in the
presence of TAT-myc (black bars), TAT-STEP WT (striped bars), and TAT-STEP C/S (gray bars) (*p < 0.05; **p< 0.01; ***p< 0.005)
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extrasynaptic GluN2B-containing NMDARs, which is
shown to cause excitotoxicity [22].
It remains unknown how prolonged activity perturb-
ation regulates STEP61. Previous studies have reportedthat Ser221 of STEP61 is dephosphorylated by calcium-
dependent calcineurin upon NMDAR activation [13] and
phosphorylated by protein kinase A (PKA) upon stimula-
tion of dopamine D1 receptor [23]. Interestingly, synaptic
scaling is shown to involve reduced calcium influx to the
Fig. 5 TAT-STEP WT blocks synaptic scaling induced by prolonged inhibition of hippocampal network activity. a–dWhole-cell patch clamp recording of
mEPSCs from cultured hippocampal neurons that were treated for 48 h with vehicle control (CTL, 0.1 % H2O) and TTX (1 μM). Prior to mEPSCs recording,
neurons were preincubated for 30 min with TAT-myc and TAT-STEP WT protein. a Representative traces of mEPSCs. b Normalized cumulative fraction of
the mEPSC amplitudes. c TAT-STEP WT abolished the TTX-induced increase in the mEPSC amplitudes. d TAT-STEP WT did not affect the mEPSC frequencies.
Data shown (c, d) represent the mean ± SEM (*p < 0.05). e Model by which activity-dependent changes in STEP61 level and activity regulate
Tyr-dephosphorylation of GluA2 and GluN2B, leading to changes in surface AMPAR and NMDAR expression during homeostatic synaptic
plasticity. Gray arrows indicate internalization. Orange arrows indicate lateral movement of surface AMPAR and NMDAR out of postsynaptic density
(light pink)
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and enhanced PKA activity at excitatory synapses [25].
Hence, prolonged activity blockade could increase Ser221-
phosphorylation of STEP61 (Fig. 2b, d) by reduced calcine-
urin activity and/or enhanced PKA activity, in addition to
decreasing STEP61 level by transcriptional down-regulation
(Fig. 1e, f). Considering that a loss of PKA from synapses
was found during synaptic downscaling [25], reduced PKA
activity may contribute to the BC-induced decrease in
Ser221-phosphorylation of STEP61 (Fig. 2c, d).Conclusions
In summary, we demonstrate a bidirectional modulation
of STEP61 level and activity by prolonged alterations of
hippocampal network activity, resulting in correlative
changes in Tyr-phosphorylation of STEP61 substrates,
GluN2B and GluA2. We also show that the reductionin STEP61 contributes to synaptic scaling. Future stud-
ies should test if this regulation alters NMDAR and
AMPAR surface density during homeostatic plasticity
(Fig. 5e). Investigating how prolonged activity perturb-
ation regulates STEP61 should provide mechanistic in-
sights into the dysregulation of STEP61 expression, which
are present in multiple neuropathologies [2].Materials and methods
Hippocampal neuronal culture
The Institutional Animal Care and Use Committee at
the University of Illinois Urbana-Champaign approved
all experimental procedures involving animals. Primary
dissociated hippocampal cultures were prepared from
Sprague–Dawley rat embryos at embryonic day 18 and
plated at high density (330 cells/mm2) as described [8].
At 10–13 days in vitro, neurons were treated for 24–48 h
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(20 μM) (all Tocris).Electrophysiology
Whole-cell patch-clamp recordings of mEPSCs (>150
events per neuron) were performed at 23–25 °C from
pyramidal neurons held at −60 mV in external solution
containing 1 μM TTX and 20 μM BC as described [12, 25]
using a Multiclamp 700B amplifier, Digidata1440A, and the
pClamp 10.2 (Molecular Devices). Signals were acquired
3 min after making the whole-cell configuration, filtered at
1 kHz, and sampled at 10 kHz on gap free mode (5 min).
The mEPSCs were detected with a 10 pA thresholds and
analyzed by Mini Analysis (Synaptosoft).QPCR
The QPCR was performed with the StepOnePlus real-
time PCR system (Applied Biosystems) using total RNA
(1–2 μg) as described [8]. The forward and reverse primer
sequences for PTPN5 were 5’-GGAGTCAGCCCATGAA
TACC-3’ and 5’-CAGACGTACCCTGCTGTGAG-3’ re-
spectively. The primer sequences for GAPDH has been
previously described [8]. Following normalization to con-
trol GAPDH cDNA levels, the fold change of PTPN5
cDNA levels for each treatment compared to control
was determined.Immunoblot analysis
Neuronal lysate samples were prepared in RIPA buffer
supplemented with protease inhibitors and Tyr phos-
phatase inhibitors (1 mM NaVO3, 10 mM Na4O7P2, and
50 mM NaF) as described [8] and were subjected to im-
munoblot analysis with primary antibodies against STEP61
(Santa Cruz), STEP61-pS
221([13]), GluN2B and GluA2
(Millipore), GluN2B-pY1472 (PhosphoSolutions), GluA2-
p3Y and GAPDH (Cell Signaling). Densitometric quantifi-
cation following normalization to GAPDH was performed
with ImageJ software (National Institutes of Health).Immunocytochemistry
Permeabilized immunostaining were performed with anti-
myc antibodies (Thermo-Scientific) as described [12, 25].
Fluorescence images of the neurons were acquired using
the same exposure time and analyzed with ImageJ to com-
pare their background-subtracted fluorescence intensities.Statistical analyses
Using Origin 9.1 (Origin Lab), the Student’s t test and
one-way ANOVA with Tukey’s and Fisher’s multiple com-
parison tests were performed to identify the statistically
significant difference with a priori value (p) < 0.05 between
2 groups and for >3 groups, respectively.Additional file
Additional file 1: Figure S1. Membrane-permeable TAT-STEP WT or C/
S proteins alter STEP61–dependent Tyr-phosphorylation of GluN2B and
GluA2. (A) Permeabilized immunostaining of cultured hippocampal neurons
at 12 days in vitro that were incubated for 30 min with no fusion proteins
(None), TAT-myc, TAT-STEP WT, or TAT-STEP C/S. Scale bars are 20 μm. (B)
Background subtracted, mean intensity of myc fluorescence (n = 10–19
images per treatment). AU, arbitrary unit. (C–D) Quantification of the
levels of Tyr1472–phosphorylated GluN2B (GluN2B-pY1472) and the level
of GluA2 that were phosphorylated at Tyr 869, Tyr 873, and Tyr 876
(GluA2-p3Y) in CTL-treated neurons (from Fig. 4b–e) that were incubated
with TAT-fusion proteins for 30 min. (C) TAT-STEP WT decreases basal
Tyr-phosphorylation of GluN2B and GluA2, confirming that TAT-STEP WT
increases STEP activity. (D) TAT-STEP C/S increases basal Tyr-phosphorylation
of GluN2B and GluA2, confirming its ability to block dephosphorylation of
STEP substrates. Data shown represent the mean ± SEM (*p < 0.05;
**p < 0.01). (PDF 969 kb)
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